Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by solublemediators

Cardiovascular Research

Volumn 105, Issue 3, 2015, Pages 260-270

  Cartledge, James E ^a   Kane, Christopher ^a   Dias, Priyanthi ^a   Tesfom, Meron ^a   Clarke, Lucy ^a   Mckee, Benjamin ^a   Al Ayoubi, Samha ^a,b   Chester, Adrian ^a   Yacoub, Magdi H ^a   Camelliti, Patrizia ^a   Terracciano, Cesare M ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Calcium handling; Fibroblasts; Paracrine communication; TGF

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM ION; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; CULTURE MEDIUM; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CELL VOLUME; CONTROLLED STUDY; CULTURE MEDIUM; ECHOCARDIOGRAPHY; FIBROBLAST CULTURE; HEART EJECTION FRACTION; HEART FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART STRESS; MYOFIBROBLAST; NONHUMAN; PRESSURE OVERLOADED HEART; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THORACIC AORTIC CONSTRICTION; TRANSIENT AMPLITUDE; TRANSVERSE TUBULAR SYSTEM; ANIMAL; CALCIUM SIGNALING; CARDIOMEGALY; CELL CULTURE; CELL SURVIVAL; COCULTURE; DISEASE MODEL; FIBROBLAST; LEWIS RAT; MEMBRANE POTENTIAL; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; TIME;

ANIMALS; CALCIUM SIGNALING; CARDIOMEGALY; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FIBROBLASTS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; MYOFIBROBLASTS; PARACRINE COMMUNICATION; PROTEIN-SERINE-THREONINE KINASES; RATS, INBRED LEW; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84930669904     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu264     Document Type: Article

References (46)

1. Nag AC. Study of non-muscle cells of the adultmammalian heart: A fine structural analysis and distribution. Cytobios 1980;28:41-61.
2. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: The renaissance cell. Circ Res 2009;105:1164-1176.
3. Weber KT. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J Hypertens 2004;22:47-50.
4. Kakkar R, Lee RT. Intramyocardial fibroblast myocyte communication. Circ Res 2010; 106:47-57.
5. Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005;65:40-51.
6. Vasquez C, Mohandas P, Louie KL, Benamer N, Bapat AC, Morley GE. Enhanced fibroblast-myocyte interactions in response to cardiac injury. Circ Res 2010;107: 1011-1020.
7. Pedrotty DM, Klinger RY, Kirkton RD, Bursac N. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res 2009;83:688-697.
8. Kaur K, Zarzoso M, Ponce-Balbuena D, Guerrero-Serna G, Hou L, Musa H, Jalife J. TGF-beta1, released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes. PLoS ONE 2013;8:e55391.
9. LaFramboise WA, Scalise D, Stoodley P, Graner SR, Guthrie RD, Magovern JA, Becich MJ. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am J Physiol Cell Physiol 2007;292:C1799-C1808.
10. Guo W, Kamiya K, Kada K, Kodama I, Toyama J. Regulation of cardiac Kv1.5 K+ channel expression by cardiac fibroblasts and mechanical load in cultured newborn rat ventricular myocytes. J Mol Cell Cardiol 1998;30:157-166.
11. Rohr S. Cardiac fibroblasts in cell culture systems: myofibroblasts all along? J Cardiovasc Pharmacol 2011;57:389-399.
12. Dawson K, Wu CT, Qi XY, Nattel S. Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells. PLoS ONE 2012;7: e52032.
13. Cohen NM, Lederer WJ. Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol 1988;406:115-146.
14. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998;40:352-363.
15. Ramos-Mondragon R, Vega AV, Avila G. Long-term modulation of Na+ and K+ channels by TGF-beta1 in neonatal rat cardiac myocytes. Pflugers Arch 2011;461:235-247.
16. 2+ current and charge movement by acting on the Cav1.2 mRNA. Am J Physiol Heart Circ Physiol 2007;292:H622-H631.
17. 2+ oscillations in cardiac myocytes. Biochem Biophys Res Commun 1994;204:678-684.
18. Li S, Li X, Zheng H, Xie B, Bidasee KR, Rozanski GJ. Pro-oxidant effect of transforming growth factor-beta1 mediates contractile dysfunction in rat ventricular myocytes. Cardiovasc Res 2008;77:107-117.
19. Van-Nieuwenhoven FA, Hemmings KE, Porter KE, Turner NA. Combined effects of interleukin-1alpha and transforming growth factor-beta1 on modulation of human cardiac fibroblast function. Matrix Biol 2013;32:399-406.
20. 2+handling and structure is regulated by degree and duration of mechanical load variation. J Cell Mol Med 2012;16:2910-2918.
21. Siedlecka U, Arora M, Kolettis T, Soppa GK, Lee J, Stagg MA, Harding SE, Yacoub MH, Terracciano CM. Effects of clenbuterol on contractility and Ca2+homeostasis of isolated rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2008;295:H1917-H1926.
22. Terracciano CM, Harding SE, Adamson D, Koban M, Tansley P, Birks EJ, Barton PJ, Yacoub MH. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J 2003;24:1329-1339.
23. Lee J, Stagg MA, Siedlecka U, Latif N, Soppa GK, Yacoub M, Terracciano CM. Identification of cell-specific soluble mediators and cellular targets during cell therapy for the treatment of heart failure. Regen Med 2008;3:953-962.
24. Ibrahim M, Al Masri A, Navaratnarajah M, Siedlecka U, Soppa GK, Moshkov A, Al-Saud SA, Gorelik J, Yacoub MH, Terracciano CM. Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface. FASEB J 2010;24:3321-3329.
25. Terracciano CM, Tweedie D, MacLeod KT. The effects of changes to action potential duration on the calcium content of the sarcoplasmic reticulum in isolated guinea-pig ventricular myocytes. Pflugers Arch 1997;433:542-544.
26. Fredj S, Bescond J, Louault C, Delwail A, Lecron JC, Potreau D. Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J Cell Physiol 2005;204:428-436.
27. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997;96:3737-3744.
28. Shivakumar K, Sollott SJ, Sangeetha M, Sapna S, Ziman B, Wang S, Lakatta EG. Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2008;294:H2653-H2658.
29. Booz GW, Dostal DE, Baker KM. Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system. Am J Cardiol 1999;83(12A): 44H-47H.
30. Fredj S, Bescond J, Louault C, Potreau D. Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J Cell Physiol 2005;202: 891-899.
31. Tsai CT, Tseng CD, Hwang JJ, Wu CK, Yu CC, Wang YC, Chen WP, Lai LP, Chiang FT, Lin JL. Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor beta1. Cardiovasc Res 2011;89:805-815.
32. Tsoporis JN, Izhar S, Proteau G, Slaughter G, Parker TG. S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. J Mol Cell Cardiol 2012;52:464-473.
33. Dolmatova E, Spagnol G, Boassa D, Baum JR, Keith K, Ambrosi C, Kontaridis MI, Sorgen PL, Sosinsky GE, Duffy HS. Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation. Am J Physiol Heart Circ Physiol 2012;303:H1208-H1218.
34. Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, Black CM, Denton CP, Abraham DJ, Leask A. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 2007;56: 4189-4194.
35. Ren A, Yan X, Lu H, Shi J, Yin Y, Bai J, YuanW, Lin L. Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes. Can J Physiol Pharmacol 2008;86: 536-540.
36. Abrial M, Da Silva CC, Pillot B, Augeul L, Ivanes F, Teixeira G, Cartier R, Angoulvant D, Ovize M, Ferrera R. Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury. J Mol Cell Cardiol 2014;68:56-65.
37. Hilal-Dandan R, He H, Martin JL, Brunton LL, Dillmann WH. Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP. Am J Physiol Heart Circ Physiol 2009;296: H728-H734.
38. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95: 1140-1153.
39. Squires CE, Escobar GP, Payne JF, Leonardi RA, Goshorn DK, Sheats NJ, Mains IM, Mingoia JT, FlackEC, Lindsey ML. Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol 2005;39:699-707.
40. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T. Cardiac fibroblast-derived micro- RNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014;124:2136-2146.
41. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010;120:254-265.
42. Accornero F, van Berlo JH, Benard MJ, Lorenz JN, Carmeliet P, Molkentin JD. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2011;109:272-280.
43. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992;262(6 Pt2):H1861-H1866.
44. Balke CW, Shorofsky SR. Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998;37:290-299.
45. Turner NA, Porter KE. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 2013;6:5.
46. Gustafsson AB, Brunton LL. Beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin- 1beta via message stabilization. Mol Pharmacol 2000;58:1470-1478.